2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!

2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!

Applications for the 2027 NMD4C–RARE.Qc Basic Science Research Summer School Are Now Open!

For the first time, the Neuromuscular Disease Network for Canada (NMD4C) in partnership with The network to advance research on rare diseases in Quebec (RARE.Qc) will be hosting the 2027 NMD4C–RARE.Qc Basic Science Research Summer School, on May 12-14, 2027, at the Université du Québec à Trois-Rivières (UQTR), led by Dr. Jean-Philippe Leduc-Gaudet.

The annual Summer School combines lecture-based learning, hands-on workshops, trainee presentations, patient-partner engagement, and networking opportunities with leading researchers from across Canada. The 2027 program will focus on inflammation and assessment of mitochondrial function, while also covering emerging methodologies relevant to rare and neuromuscular diseases.

Key Details

  • Application Deadline: December 1, 2026
  • Anticipated Notice of Decision: Mid-December 2026
  • Program Dates: May 12 to 14, 2027
  • Location: Université du Québec à Trois-Rivières (UQTR), Trois-Rivières, Québec
  • Eligibility: Graduate students, postdoctoral fellows, and junior research staff conducting neuromuscular and rare disease-focused research at a Canadian institution
  • Travel and Accommodation Support: Available for non-local participants

Featured Speakers Include

  • Dr. Hanns Lochmüller (Keynote Speaker)
  • Dr. Marie-Claude Sincennes
  • Dr. Cam-Tu Nguyen
  • Dr. Vincent Picher-Martel
  • Dr. Jacques P. Tremblay
  • Dr. Marc Germain
  • Dr. Geneviève Pépin
  • Dr. Yannick Audet-Delage

Eligibility requirements, application instructions, and details regarding accommodation and travel support are available on the 2027 NMD4C–RARE.Qc Basic Science Research Summer School webpage.

If you have any questions about the 2027 Summer School, please reach out to our Network Manager, Erin Beattie

Apply or Share this Opportunity with Trainees in Your Network.

 

2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!

Read next...

CPNG 2026

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.